Cargando…

ODP312 Giant Silent Corticotroph Adenoma: Presentation of 3 Cases

INTRODUCTION: Silent corticotroph adenoma (SCA) is a T-pit lineage cells-derived tumor without clinical presentation of Cushing's disease and normal cortisol dynamics (totally silent) or elevated ACTH/abnormal cortisol dynamics (clinically silent). SCAs account for 10-20% of silent pituitary ad...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oliveira, Miriam C, Corso, Eduardo Raul B, Pereira-Lima, Ana Paula S, Rech, Carolina GSL, Pereira-Lima, Julia Fernanda S, Nesello, Alberto C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Neuroendocrinology and Pituitary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625178/ http://dx.doi.org/10.1210/jendso/bvac150.1021

Ejemplares similares

ODP339 Nonfunctioning Giant Adenomas
por: Oliveira, Miriam C, et al.
Publicado: (2022)

A Case of Silent Corticotroph Adenoma
por: Ibekwe, Usonwanne U, et al.
Publicado: (2021)

ODP351 Silent Corticotroph Adenomas – Characteristics and Comparisons to Other Non-functioning Pituitary Adenomas: A Case Series
por: Di Ieva, Antonio, et al.
Publicado: (2022)

MON-469 Pituitary Corticotroph Lesions: Clinical, Biochemical, and Pathological Characterization of Cushing Disease, Silent Corticotroph Adenomas, and Corticotroph Hyperplasia
por: Castlen, Joseph, et al.
Publicado: (2019)

LBODP079 A Case of Silent Invasive Corticotroph Adenoma
por: Bendaram, Snigdha Reddy, et al.
Publicado: (2022)

ODP355 The analysis of tumor infiltrative lymphocytes in corticotroph adenomas and its relation to hormonal status
por: Fukuoka, Hidenoi, et al.
Publicado: (2022)

PMON122 Unveiling the Kraken- An Incidentally Found Silent Corticotroph Adenoma of the Pituitary Gland
por: Shteyman, Sara, et al.
Publicado: (2022)

SAT-LB57 The Spectrum of Genomic and Transcriptomic Alterations in ACTH-Producing and ACTH-Silent Corticotroph Adenomas
por: Lerario, Antonio Marcondes, et al.
Publicado: (2020)

ODP338 Neuromedin B Receptor Antagonist Suppresses ACTH Secretion and Cell Proliferation in Human and Mouse Corticotroph Adenoma
por: Atsumi, Tatsuya, et al.
Publicado: (2022)

ODP301 Corticotroph Macroadenomas with Extensions to Third Ventricle: Four Case Reports
por: Suzuki, Yasuhiro, et al.
Publicado: (2022)

MON-309 Prevalence of Silent Corticotroph Adenomas in a Large Cohort of Nonfunctioning Pituitary Adenomas: Plasma Proopiomelanocortin(POMC) Levels and Response to Pasireotide LAR
por: Reyes-Vidal, Carlos, et al.
Publicado: (2020)

New Transcriptional Insights into Silent and Active Corticotroph Pituitary Tumors at Single Cell Resolution
por: Zhang, Dongyun, et al.
Publicado: (2021)

Co Existence of a Corticotroph Adenoma and a Multifunctional Pituitary Cyst
por: McDonnell, David John, et al.
Publicado: (2021)

SAT-259 Acromegaly by Pituitary Adenoma Associated with ACTH-Independent Cushing Syndrome by Adrenal Carcinoma: Case Report
por: Minuzzi, Ricardo Kunde, et al.
Publicado: (2020)

ODP311 Giant-versus Macroadenomas: Does Size Really Matter in Pituitary Somatotroph Adenomas?
por: Sendur, Suleyman Nahit, et al.
Publicado: (2022)

OR23-04 SST5 Expression and USP8 Mutation in Functioning and Silent Corticotroph Pituitary Tumors
por: castellnou, Solene, et al.
Publicado: (2020)

Silent Pituitary Adenoma in Nasal Cavity
por: Bashir, Bilal, et al.
Publicado: (2021)

SAT618 Uncovering The Role Of O-glcnacylation In Pituitary Adenoma Pathogenesis: Insights From Corticotroph Tumors
por: Massman, Logan J, et al.
Publicado: (2023)

FRI301 Prolactin And Obesity: Analysis Off Weight Oscillation In The Follow-up Of Macroprolactinomas
por: Oliveira, Miriam C, et al.
Publicado: (2023)

Neuromedin B Receptor Antagonist Suppresses Pomc Expression in AtT-20 Cells and Human Corticotroph Adenoma Cells
por: Sekizaki, Tomonori, et al.
Publicado: (2021)

SUN-312 Strikingly Low Prevalence of Pituitary Incidentalomas in Our Hospital
por: Sosa, Natalia, et al.
Publicado: (2020)

THU010 A Case Of Cushing(')s Disease Due To T-pit Positive, ACTH Negative Aggressive Corticotroph Pituitary Adenoma
por: Gopinath, Chaitra, et al.
Publicado: (2023)

THU099 The Challenging Management Of Silent Corticotroph PitNET—From Very Aggressive To Mild Course Of Disease During Long Follow Up
por: Bogusławska, Anna, et al.
Publicado: (2023)

ODP618 The profile of patients with ACTH-secreting pituitary adenomas and subclinical pituitary apoplexy
por: Tatsi, Christina, et al.
Publicado: (2022)

Potential Role for the RASD1 Glucocorticoid-Responsive Gene in Corticotroph Tumorigenesis
por: Hernández-Ramírez, Laura C, et al.
Publicado: (2021)

Clinical Correlation to E-cadherin and Granulation Patterns in Corticotroph Tumors
por: Lipe, Kristin A, et al.
Publicado: (2021)

Long-Term Corticotroph Function Following Cure of Cushing’s Syndrome
por: Schernthaner-Reiter, Marie Helene, et al.
Publicado: (2021)

MON-312 The Effects of Cabergoline in Pre-Surgical and Recurrence Periods of Cushing’s Disease Patients
por: Pereira, Ana Julia Garcia, et al.
Publicado: (2020)

ODP286 A Case of Synchronous Growth Hormone and Adrenocorticotrophic Hormone Secretion in a Patient with an Incidental Pituitary Adenoma.
por: Maraqa, Sima, et al.
Publicado: (2022)

OR06-03 Serotonin Regulates Corticotroph Tumor Cell Proliferation and ACTH Secretion
por: Zhang, Dongyun, et al.
Publicado: (2020)

PI3K Inhibition by BKM120 Results in Antiproliferative Effects on Corticotroph Tumor Cells
por: Oliveira, Helen A, et al.
Publicado: (2021)

Desmopressin Test in Silent Corticothoph Pituitary Adenomas, a Preliminary Study - a Comparison With Cushing Disease
por: Huayllas, Martha Katherine, et al.
Publicado: (2021)

FRI312 Diplopia And Headache After Treatment With GnRH Agonist
por: Zakkar, Adam A, et al.
Publicado: (2023)

MON-406 Two Cases of Aggressive Corticotroph Pituitary Tumors Treated with Capecitabine and Temozolomide
por: Tateno, Tae, et al.
Publicado: (2019)

SAT-311 Role of SREBP in Regulation of Corticotroph Tumor ACTH Secretion and Cell Proliferation
por: Zhang, Dongyun, et al.
Publicado: (2020)

ODP298 Are there identifiable differences in pituitary adenoma width, extension, invasion, or cystic degeneration in subclinical compared to clinical pituitary apoplexy patients?
por: Heffernan-Marks, Ariella, et al.
Publicado: (2022)

THU078 The Definition And Epidemiology Of Giant Pituitary GH-Secreting Adenomas Based On Clinical, Imaging, And Hormonal Parameters: A Pilot Study
por: Del Corso, Leticia Marinho, et al.
Publicado: (2023)

FRI319 Diagnostic And Management Challenges In A Patient With A Giant Pituitary Lactosomatotroph Adenoma
por: Peixe, Carolina Ribeiro, et al.
Publicado: (2023)

OR2803 Corticotroph Fate Weighted Cell Differentiation Paradigm For Human Induced Pluripotent Stem Cells
por: Elyse Moore, M, et al.
Publicado: (2023)

MON-295 Desmopressin Test in Silent Corticothoph Pituitary Adenomas, a Preliminary Study - a Comparison with Cushing Disease
por: Huayllas, Martha Katherine, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vc156a4h8dvde4mtvtfm4f9f9n